Michael Lee

Array ( [id] => 3828627 [patent_doc_number] => 05783681 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Androgen regulation with DNA sequences of rat probasin gene' [patent_app_type] => 1 [patent_app_number] => 8/351365 [patent_app_country] => US [patent_app_date] => 1995-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11594 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783681.pdf [firstpage_image] =>[orig_patent_app_number] => 351365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889792 [patent_doc_number] => 05714666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells' [patent_app_type] => 1 [patent_app_number] => 8/396200 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6066 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714666.pdf [firstpage_image] =>[orig_patent_app_number] => 396200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4325026 [patent_doc_number] => 06331658 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Genetically engineered mammals for use as organ donors' [patent_app_type] => 1 [patent_app_number] => 8/379040 [patent_app_country] => US [patent_app_date] => 1995-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11267 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331658.pdf [firstpage_image] =>[orig_patent_app_number] => 379040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828660 [patent_doc_number] => 05783683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Antisense oligonucleotides which reduce expression of the FGFRI gene' [patent_app_type] => 1 [patent_app_number] => 8/371001 [patent_app_country] => US [patent_app_date] => 1995-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12088 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783683.pdf [firstpage_image] =>[orig_patent_app_number] => 371001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738523 [patent_doc_number] => 05753499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Viral vector complexes having adapters of predefined valence' [patent_app_type] => 1 [patent_app_number] => 8/363137 [patent_app_country] => US [patent_app_date] => 1994-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9979 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753499.pdf [firstpage_image] =>[orig_patent_app_number] => 363137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103714 [patent_doc_number] => 06051559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Cloning and characterizing of genes associated with long-term memory' [patent_app_type] => 1 [patent_app_number] => 8/361063 [patent_app_country] => US [patent_app_date] => 1994-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 18 [patent_no_of_words] => 42732 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051559.pdf [firstpage_image] =>[orig_patent_app_number] => 361063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3814864 [patent_doc_number] => 05789388 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity' [patent_app_type] => 1 [patent_app_number] => 8/359980 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4038 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789388.pdf [firstpage_image] =>[orig_patent_app_number] => 359980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890528 [patent_doc_number] => 05723718 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Induction of immune tolerance to tumor cells' [patent_app_type] => 1 [patent_app_number] => 8/359760 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3991 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723718.pdf [firstpage_image] =>[orig_patent_app_number] => 359760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4418662 [patent_doc_number] => 06177242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Genomic DNA fragments containing regulatory and coding sequences for the .beta.2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments' [patent_app_type] => 1 [patent_app_number] => 8/358627 [patent_app_country] => US [patent_app_date] => 1994-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 12 [patent_no_of_words] => 14862 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177242.pdf [firstpage_image] =>[orig_patent_app_number] => 358627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3744291 [patent_doc_number] => 05716821 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Prevention and treatment of respiratory tract disease' [patent_app_type] => 1 [patent_app_number] => 8/316438 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8859 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716821.pdf [firstpage_image] =>[orig_patent_app_number] => 316438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4017166 [patent_doc_number] => 05880327 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Transgenic mammals expressing human coagulation factor VIII' [patent_app_type] => 1 [patent_app_number] => 8/308518 [patent_app_country] => US [patent_app_date] => 1994-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6337 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880327.pdf [firstpage_image] =>[orig_patent_app_number] => 308518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3832993 [patent_doc_number] => 05712256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Ribonucleotide preparations and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/309958 [patent_app_country] => US [patent_app_date] => 1994-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9183 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712256.pdf [firstpage_image] =>[orig_patent_app_number] => 309958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009351 [patent_doc_number] => 05962410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Inhibition of eucaryotic pathogens with lytic peptides' [patent_app_type] => 1 [patent_app_number] => 8/301733 [patent_app_country] => US [patent_app_date] => 1994-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11025 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962410.pdf [firstpage_image] =>[orig_patent_app_number] => 301733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109325 [patent_doc_number] => 06045790 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Vaccines for equine influenza' [patent_app_type] => 1 [patent_app_number] => 7/939556 [patent_app_country] => US [patent_app_date] => 1992-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4960 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/045/06045790.pdf [firstpage_image] =>[orig_patent_app_number] => 939556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4299673 [patent_doc_number] => 06326003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Manganese superoxide dismutase cloning and expression in microorganisms' [patent_app_type] => 1 [patent_app_number] => 6/918534 [patent_app_country] => US [patent_app_date] => 1986-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 6114 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326003.pdf [firstpage_image] =>[orig_patent_app_number] => 918534 [rel_patent_id] =>[rel_patent_doc_number] =>)